Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ESMO Breast Cancer Annual Congress 2023
2023 ASCO Annual Meeting
2023 Society of Surgical Oncology International Conference on Surgical Cancer Care
24th ASBrS Annual Meeting
AACR Annual Meeting 2023
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Topics
Advertisement
Solid Tumors
Bladder Cancer
Breast Cancer
CNS Cancers
Colorectal Cancer
Gastroesophageal Cancer
Gastrointestinal Cancer
Gynecologic Cancers
Head and Neck Cancer
Hepatobiliary Cancer
Kidney Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Thyroid Cancer
Neuroendocrine Tumors
Hematologic Malignancies
Leukemia
Lymphoma
Lymphoma (Curated)
Multiple Myeloma
Myelodysplastic Syndromes
Issues in Oncology
Cost of Care
Geriatric Oncology
Global Cancer Care
Health-Care Policy
Legislation
Survivorship
Genomics/Genetics
Immunotherapy
COVID-19
Supportive Care
Integrative Oncology
Pain Management
Palliative Care
Symptom Management
Advertisement
Advertisement
Jun
04
Today In Oncology
Vorasidenib Delays Disease Progression or Death in Patients With Grade 2 IDH-Mutated Glioma
Radiation May Be Safely Omitted in Select Patients With Locally Advanced Rectal Cancer
Adjuvant Osimertinib Improves Survival in Patients With Resected EGFR-Mutated NSCLC
Nivolumab May Reduce Risk of Disease Progression or Death in Previously Untreated Patients With Hodgkin Lymphoma Compared to Brentuximab Vedotin
Mirvetuximab Soravtansine Improves Survival in Patients With Recurrent Ovarian Cancer
View More
Advertisement
